{"id":262556,"date":"2026-07-13T19:07:26","date_gmt":"2026-07-13T16:07:26","guid":{"rendered":"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/"},"modified":"2026-07-13T19:07:26","modified_gmt":"2026-07-13T16:07:26","slug":"herbal-treatment-of-major-depression-mendelson-scott-d","status":"publish","type":"post","link":"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/","title":{"rendered":"Herbal Treatment Of Major Depression &#8211; Mendelson, Scott D.;"},"content":{"rendered":"<figure style=\"text-align:center;margin:0 auto 1.5em;\"><img decoding=\"async\" src=\"https:\/\/1kitap1.com\/en\/wp-content\/uploads\/2026\/07\/44f0f07cf58c5acd.jpg\" alt=\"Herbal Treatment of Major Depression - Mendelson, Scott D.; book cover\" style=\"max-width:300px;width:100%;height:auto;box-shadow:0 4px 12px rgba(0,0,0,.25);border-radius:4px;\"\/><\/figure>\n<p>The German Commission E has approved Humulus lupulus for the treatment of restlessness, anxiety, mood disturbances, and sleep disturbances.12 In an open-labeled study, nightly consumption of non- alcoholic beer, a good source of Humulus lupulus, significantly improved sleep and eased anxiety.13 There is only one published report on the effects of Humulus lupulus on MDD in human subjects. In a small, but randomized, placebo-controlled, double-blind study, the effects of Humulus lupulus were tested in otherwise healthy young adults with evidence of mild depression or anxiety per the Depression Anxiety Stress Scale-21.<\/p>\n<p>After four weeks of treatment, Humulus lupulus produced significant improvements in depression and anxiety scores. AM cortisol levels were also measured, but no differences were noted between treatment and control groups.14 The 8-prenylnaringenin found in Humulus lupulus is a potent phytoestrogen.15 In a prospective, randomized, double-blind, placebo- controlled study, extracts of Humulus lupulus standardized to contain 8- prenylnaringenin (100 \u03bcg or 250 \u03bcg per dose) relieved symptoms in menopausal women. The responses were determined by means of a modified Kupperman index and a patients\u2019 questionnaire. Unfortunately, specific mood data was not included.16 7.33.6 Dosage Marciano and Vizniak recommend dosage of 1 cup three times a day of infusion from 1 teaspoon of Humulus lupulus per cup.<\/p>\n<p>Alternatively, they suggest tincture (1:5, 60%) 2\u20133ml three times a day.17 7.33.7 Toxicity Toxicological studies in animals stated that LD50 for orally administered hop extract in mice ranges from 500\u20133,500 mg\/kg.18 Extrapolated to a 75 kg human adult, these doses would be approximately 35\u2013245 g. 7.33.8 Safety in Pregnancy The Botanical Safety Handbook notes there is no definitive guidance from the literature concerning the safety of this herb during pregnancy.19 7.33.9 Drug Interactions The Botanical Safety Handbook notes no known interactions with drugs. Extracts of Humulus lupulus do significantly inhibit a variety of cytochrome P450 enzymes, including CYP2C8, CYP2C9, CYP2C19, and 1.<\/p>\n<p>Biendl M, Pinzl C. Hops and Health. Uses, Effects, History. Wolznach: German Hop Museum Wolznach; 2008. 2. Miranda CL, Stevens JF, Ivanov V, et al. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem. 2000;48(9):3876\u20133884. 3.<\/p>\n<blockquote>\n<p>Navindra P. Seeram and Luigi Antonio Morrone Botanical medicines are rapidly increasing in global recognition, with significant public health and economic implications. For instance, in developing countries, a vast majority of the indigenous populations use medicinal plants as a major form of healthcare. Also, in industrialized nations, including Europe and North America, consumers are increasingly using herbs and botanical dietary supplements as part of integrative health and complementary and alternative therapies.<\/p>\n<p>Moreover, the paradigm shifts occurring in modern medicine, from mono-drug to multi-drug and poly- pharmaceutical therapies, has led to renewed interest in botanical medicines and botanical drugs. Natural Products and Cardiovascular Health Catherina C. Caballero George Aromatherapy Basic Mechanisms and Evidence-Based Clinical Use Giacinto Bagetta, Marco Cosentino, and Tsukasa Sakurada Herbal Medicines Development and Validation of Plant-Derived Medicines for Human Health Giacinto Bagetta, Marco Cosentino, Marie Tiziana Corasaniti, and Shinobu Sakurada Natural Products Interactions on Genomes Siva G. Somasundaram Principles and Practice of Botanicals as an Integrative Therapy Anne Hume and Katherine Kelly Orr Herbal Treatment of Major Depression: Scientific Basis and Practical Use Scott Mendelson OceanofPDF.com Herbal Treatment of Major Depression Scientific Basis and Practical Use Scott D.<\/p>\n<p>Mendelson, MD, PhD OceanofPDF.com CRC Press Taylor &#038; Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 \u00a9 2020 by Taylor &#038; Francis Group, LLC CRC Press is an imprint of Taylor &#038; Francis Group, an Informa business No claim to original U.S. Government works International Standard Book Number-13: 978-0-367-37532-4 (Hardback) International Standard Book Number-13: 978-0-429-35551-6 (eBook) This book contains information obtained from authentic and highly regarded sources.<\/p>\n<p>Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint.<\/p>\n<p>Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (www.copyright.com\/) or contact the Copyright Clearance Center, Inc.<\/p>\n<p>(CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe.<\/p>\n<\/blockquote>\n<p><em>This is a short excerpt from the opening of &ldquo;Herbal Treatment of Major Depression&rdquo; by Mendelson, Scott D.;, quoted for review and introduction purposes. All rights belong to the copyright holders.<\/em><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/#Book_Information\" >Book Information<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/#Reading_Word_Statistics\" >Reading &amp; Word Statistics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/#Most_Frequent_Words\" >Most Frequent Words<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/#Table_of_Contents\" >Table of Contents<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/1kitap1.com\/en\/herbal-treatment-of-major-depression-mendelson-scott-d\/#PDF_Download\" >PDF Download<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Book_Information\"><\/span>Book Information<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Unique ID:<\/strong> 44f0f07cf58c5acd<\/li>\n<li><strong>File Extension:<\/strong> .pdf<\/li>\n<li><strong>File Size:<\/strong> 5,749,132 bytes (5.483 MB)<\/li>\n<li><strong>Title:<\/strong> Herbal Treatment of Major Depression<\/li>\n<li><strong>Author:<\/strong> Mendelson, Scott D.;<\/li>\n<li><strong>ISBN:<\/strong> 9780367375324, 9780429355516<\/li>\n<li><strong>Pages:<\/strong> 569<\/li>\n<li><strong>Language:<\/strong> English (en)<\/li>\n<li><strong>Digital Edition Created:<\/strong> 2026-03-02T21:02:26+00:00<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Reading_Word_Statistics\"><\/span>Reading &amp; Word Statistics<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Estimated Reading Time:<\/strong> 920.8 minutes<\/li>\n<li><strong>Total Words:<\/strong> 184,160<\/li>\n<li><strong>Total Characters:<\/strong> 1,303,020<\/li>\n<li><strong>Average Words per Page:<\/strong> 323.66<\/li>\n<li><strong>Average Characters per Page:<\/strong> 2290.02<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Most_Frequent_Words\"><\/span>Most Frequent Words<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>effects (2335), also (921), antidepressant (797), mice (790), extract (706), treatment (663), rats (638), antidepressant-like (556), levels (556), effect (556), antioxidant (554), human (544), depression (489), acid (480), activity (466), stress (463), study (460), anti-inflammatory (440), brain (412), found (408), reduced (406), safety (395), chronic (381), studies (366), syndrome (350), test (342), mdd (341), forced (327), used (294), interactions (292), drug (292), pregnancy (289), inflammatory (284), swim (278), immobility (274), insulin (270), officinalis (267), med (266), bdnf (265), toxicity (257), increased (257), res (257), administration (254), oxidative (250), antidiabetic (245), however (244), preclinical (239), herb (238), use (236), herbal (226), one (222), induced (220), extracts (220), patients (217), dosage (216), herbs (213), medicine (212), chinese (208), decreased (205), anti-metabolic (199), cells (199), similar (195), liver (195), hippocampus (190), serum (188), pharmacol (180), damage (176), anxiety (176), tail (175), shown (175), suspension (174), many (171), references (165), significantly (165), rat (164), due (163), well (163), activation (162), tests (160), food (158), expression (158), plant (158), phytochemicals (155), receptor (154), thus (154), model (154), activities (153), glucose (153), flavonoids (152), symptoms (152), botanical (150), including (150), animals (149), inflammation (148), increases (148), sci (146), oil (146), showed (145), antidepressants (143), review (143).<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Table_of_Contents\"><\/span>Table of Contents<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Page 2: Cover<\/li>\n<li>Page 4: Half-Title<\/li>\n<li>Page 5: Series<\/li>\n<li>Page 7: Title<\/li>\n<li>Page 8: Copyright<\/li>\n<li>Page 10: Contents<\/li>\n<li>Page 38: Author<\/li>\n<li>Page 39: Chapter 1 Major Depression: A Brief History of Western Medical Treatment<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 46: References<\/li>\n<li>Page 48: Chapter 2 How Antidepressants Work, but Often Do Not<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 53: References<\/li>\n<li>Page 55: Chapter 3 Clues Revealed by Ketamine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 60: References<\/li>\n<li>Page 63: Chapter 4 New Understanding of the Nature and Causes of Major Depression<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 63: 4.1 Oxidative and Nitrosative Damage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 66: 4.2 Inflammation<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 70: 4.3 Chronic Stress<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 71: 4.4 Insulin Resistance<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 72: 4.5 Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 73: 4.6 Summary<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 74: References<\/li>\n<li>Page 79: Chapter 5 Phytochemicals: Some Basics<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 79: 5.1 Carbohydrates<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 80: 5.2 Lipids<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 81: 5.3 Terpenes<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 83: 5.4 Phenolics<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 83: 5.4.1 Flavonoids<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 84: 5.4.2 Non-Flavonoid Phenolics<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 85: 5.5 Alkaloids<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 86: 5.6 Summary<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 86: References<\/li>\n<li>Page 89: Chapter 6 Models and Paradigms for Assessment of Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 89: 6.1 Antioxidant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 91: 6.2 Anti-Inflammatory Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 93: 6.3 Antidiabetic\/Anti-Metabolic Syndrome Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 94: 6.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 94: 6.4.1 Forced Swim Test<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 96: 6.4.2 Tail Suspension Test<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 97: 6.4.3 Sucrose Consumption Test<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 98: 6.4.4 Test Conditions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 99: References<\/li>\n<li>Page 101: Chapter 7 Herbs with Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 101: 7.1 Allium sativum (Garlic)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 102: 7.1.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 103: 7.1.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 104: 7.1.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 105: 7.1.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 106: 7.1.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 106: 7.1.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 106: 7.1.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 106: 7.1.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 106: 7.1.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 108: 7.2 Angelica Sinensis<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 109: 7.2.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 109: 7.2.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 110: 7.2.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 110: 7.2.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 111: 7.2.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 111: 7.2.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 112: 7.2.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 112: 7.2.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 112: 7.2.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 112: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 113: 7.3 Apium graveolens (Celery)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 114: 7.3.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 114: 7.3.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 114: 7.3.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 115: 7.3.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 116: 7.3.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 116: 7.3.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 117: 7.3.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 117: 7.3.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 117: 7.3.9 Drug Interaction<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 118: 7.4 Astragalus membranaceus<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 119: 7.4.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 120: 7.4.2 Anti-inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 120: 7.4.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 120: 7.4.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 121: 7.4.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 121: 7.4.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 122: 7.4.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 122: 7.4.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 122: 7.4.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 122: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 123: 7.5 Atractylodes macrocephala<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 124: 7.5.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 124: 7.5.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 124: 7.5.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 125: 7.5.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 125: 7.5.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 126: 7.5.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 126: 7.5.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 126: 7.5.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 126: 7.5.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 126: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 127: 7.6 Avena sativa (Common Oat)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 127: 7.6.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 128: 7.6.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 128: 7.6.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 128: 7.6.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 129: 7.6.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 129: 7.6.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 129: 7.6.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 129: 7.6.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 129: 7.6.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 130: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 131: 7.7 Bacopa monnieri<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 131: 7.7.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 132: 7.7.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 132: 7.7.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 133: 7.7.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 133: 7.7.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 134: 7.7.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 134: 7.7.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 134: 7.7.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 134: 7.7.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 134: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 135: 7.8 Borage officinalis (European Borage)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 136: 7.8.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 136: 7.8.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 136: 7.8.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 136: 7.8.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 137: 7.8.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 137: 7.8.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 138: 7.8.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 138: 7.8.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 138: 7.8.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 138: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 139: 7.9 Bupleurum chinense<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 139: 7.9.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 140: 7.9.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 140: 7.9.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 141: 7.9.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 141: 7.9.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 141: 7.9.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 142: 7.9.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 142: 7.9.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 142: 7.9.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 142: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 143: 7.10 Camellia sinensis (Tea)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 144: 7.10.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 144: 7.10.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 144: 7.10.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 145: 7.10.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 145: 7.10.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 146: 7.10.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 146: 7.10.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 146: 7.10.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 146: 7.10.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 147: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 148: 7.11 Cannabis<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 149: 7.11.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 149: 7.11.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 150: 7.11.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 150: 7.11.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 152: 7.11.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 154: 7.11.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 154: 7.11.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 154: 7.11.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 155: 7.11.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 155: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 158: 7.12 Cecropia<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 158: 7.12.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 158: 7.12.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 159: 7.12.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 159: 7.12.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 160: 7.12.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 160: 7.12.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 160: 7.12.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 160: 7.12.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 161: 7.12.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 161: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 162: 7.13 Centella asiatica (Gotu Kola)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 162: 7.13.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 163: 7.13.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 163: 7.13.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 163: 7.13.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 164: 7.13.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 165: 7.13.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 165: 7.13.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 165: 7.13.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 165: 7.13.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 165: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 167: 7.14 Chrysactinia mexicana<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 167: 7.14.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 167: 7.14.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 167: 7.14.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 168: 7.14.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 168: 7.14.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 168: 7.14.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 168: 7.14.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 169: 7.14.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 169: 7.14.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 169: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 170: 7.15 Cimicifuga racemosa (Black Cohosh)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 170: 7.15.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 171: 7.15.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 171: 7.15.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 172: 7.15.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 173: 7.15.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 174: 7.15.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 174: 7.15.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 174: 7.15.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 174: 7.15.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 175: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 176: 7.16 Cinnamomum zeylanicum (Cinnamon)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 176: 7.16.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 177: 7.16.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 178: 7.16.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 179: 7.16.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 180: 7.16.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 180: 7.16.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 180: 7.16.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 180: 7.16.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 181: 7.16.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 181: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 182: 7.17 Coffea arabica (Coffee)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 183: 7.17.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 183: 7.17.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 184: 7.17.3 Antidiabetic\/Anti-Metabolic syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 184: 7.17.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 186: 7.17.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 186: 7.17.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 186: 7.17.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 186: 7.17.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 186: 7.17.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 187: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 188: 7.18 Coriandrum sativum (Coriander)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 189: 7.18.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 190: 7.18.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 190: 7.18.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 190: 7.18.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 191: 7.18.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 191: 7.18.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 191: 7.18.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 191: 7.18.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 192: 7.18.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 192: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 193: 7.19 Corydalis yanhusuo<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 193: 7.19.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 194: 7.19.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 194: 7.19.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 194: 7.19.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 195: 7.19.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 195: 7.19.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 195: 7.19.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 196: 7.19.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 196: 7.19.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 196: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 197: 7.20 Crocus sativa (Saffron)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 197: 7.20.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 198: 7.20.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 199: 7.20.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 199: 7.20.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 200: 7.20.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 201: 7.20.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 201: 7.20.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 201: 7.20.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 201: 7.20.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 201: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 203: 7.21 Curcuma longa (Turmeric)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 204: 7.21.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 204: 7.21.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 204: 7.21.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 204: 7.21.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 205: 7.21.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 205: 7.21.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 205: 7.21.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 206: 7.21.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 206: 7.21.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 206: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 207: 7.22 Cyperus rotundus<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 208: 7.22.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 208: 7.22.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 209: 7.22.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 209: 7.22.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 209: 7.22.5 Human Antidepressant Studies<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 209: 7.22.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 210: 7.22.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 210: 7.22.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 210: 7.22.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 210: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 211: 7.23 Echium amoenum<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 212: 7.23.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 212: 7.23.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 212: 7.23.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 212: 7.23.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 212: 7.23.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 213: 7.23.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 213: 7.23.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 213: 7.23.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 213: 7.23.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 213: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 214: 7.24 Eleutherococcus senticoccus (Siberian Ginseng)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 215: 7.24.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 215: 7.24.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 216: 7.24.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 216: 7.24.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 217: 7.24.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 217: 7.24.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 217: 7.24.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 217: 7.24.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 218: 7.24.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 218: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 219: 7.25 Epimedium brevicornum (Horny Goat Weed)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 219: 7.25.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 220: 7.25.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 220: 7.25.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 221: 7.25.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 222: 7.25.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 222: 7.25.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 222: 7.25.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 223: 7.25.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 223: 7.25.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 223: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 224: 7.26 Foeniculum vulgare (Fennel)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 225: 7.26.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 225: 7.26.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 226: 7.26.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 226: 7.26.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 226: 7.26.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 227: 7.26.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 227: 7.26.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 227: 7.26.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 227: 7.26.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 228: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 229: 7.27 Ginkgo biloba<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 230: 7.27.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 230: 7.27.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 230: 7.27.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 231: 7.27.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 232: 7.27.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 233: 7.27.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 233: 7.27.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 233: 7.27.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 233: 7.27.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 233: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 235: 7.28 Glycyrrhiza (Licorice)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 235: 7.28.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 236: 7.28.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 236: 7.28.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 236: 7.28.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 237: 7.28.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 237: 7.28.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 237: 7.28.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 237: 7.28.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 238: 7.28.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 238: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 239: 7.29 Hedyosmum brasiliense<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 239: 7.29.1 Antioxidant\/Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.2 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.3 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.4 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.5 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.6 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 240: 7.29.7 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 241: 7.29.8 Drug Interaction<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 241: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 241: 7.30 Hemerocallis citrina (Daylily)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 242: 7.30.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 242: 7.30.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 242: 7.30.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 243: 7.30.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: 7.30.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: 7.30.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: 7.30.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: 7.30.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: 7.30.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 244: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 245: 7.31 Hericium erinaceus (Lion\u2019s Mane)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 246: 7.31.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 246: 7.31.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 247: 7.31.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 247: 7.31.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 248: 7.31.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 249: 7.31.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 249: 7.31.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 249: 7.31.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 249: 7.31.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 250: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 251: 7.32 Hibiscus rosa-sinensis (Hibiscus)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 251: 7.32.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 252: 7.32.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 252: 7.32.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 252: 7.32.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: 7.32.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: 7.32.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: 7.32.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: 7.32.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: 7.32.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 253: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 254: 7.33 Humulus lupulus (Hops)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 255: 7.33.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 255: 7.33.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 256: 7.33.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 256: 7.33.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 256: 7.33.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 257: 7.33.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 257: 7.33.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 257: 7.33.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 258: 7.33.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 258: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 259: 7.34 Huperzia serrata<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 259: 7.34.1 Antioxidant\/Anti-Inflammatory Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 260: 7.34.2 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 260: 7.34.3 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 261: 7.34.4 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 262: 7.34.5 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 262: 7.34.6 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 262: 7.34.7 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 262: 7.34.8 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 262: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 264: 7.35 Hypericum perforatum (St John\u2019s wort)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 264: 7.35.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 264: 7.35.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 265: 7.35.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 265: 7.35.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 267: 7.35.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 268: 7.35.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 268: 7.35.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 268: 7.35.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 268: 7.35.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 269: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 271: 7.36 Ilex paraguariensis (Yerba Mate)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 271: 7.36.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 271: 7.36.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 272: 7.36.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 272: 7.36.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 273: 7.36.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 273: 7.36.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 273: 7.36.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 273: 7.36.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 273: 7.36.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 274: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 275: 7.37 Lavandula (Lavender)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 275: 7.37.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 275: 7.37.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 276: 7.37.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 277: 7.37.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 277: 7.37.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 278: 7.37.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 278: 7.37.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 278: 7.37.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 278: 7.37.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 279: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 280: 7.38 Ligusticum chuanxiong<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 281: 7.38.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 281: 7.38.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 281: 7.38.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 281: 7.38.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 282: 7.38.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 282: 7.38.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 282: 7.38.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 282: 7.38.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 282: 7.38.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 283: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 283: 7.39 Magnolia officinalis<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 284: 7.39.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 284: 7.39.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 285: 7.39.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 285: 7.39.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 287: 7.39.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 287: 7.39.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 287: 7.39.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 287: 7.39.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 288: 7.39.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 288: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 289: 7.40 Matricaria recutita (Chamomile)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 290: 7.40.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 290: 7.40.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 291: 7.40.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 292: 7.40.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 293: 7.40.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 293: 7.40.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 293: 7.40.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 294: 7.40.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 294: 7.40.9 Drug Interaction<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 294: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 296: 7.41 Melissa officinalis (Lemon Balm)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 296: 7.41.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 297: 7.41.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 297: 7.41.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 298: 7.41.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 298: 7.41.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 299: 7.41.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 299: 7.41.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 299: 7.41.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 299: 7.41.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 299: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 300: 7.42 Mimosa pudica<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 301: 7.42.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 301: 7.42.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 302: 7.42.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 302: 7.42.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 302: 7.42.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 303: 7.42.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 303: 7.42.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 303: 7.42.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 303: 7.42.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 303: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 304: 7.43 Ocimum basilicum (Sweet Basil)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 305: 7.43.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 305: 7.43.2 Anti-inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 305: 7.43.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 306: 7.43.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 307: 7.43.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 308: 7.43.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 308: 7.43.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 308: 7.43.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 308: 7.43.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 308: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 309: 7.44 Origanum vulgare (Oregano)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 310: 7.44.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 310: 7.44.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 311: 7.44.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 311: 7.44.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 312: 7.44.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 312: 7.44.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 312: 7.44.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 312: 7.44.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 313: 7.44.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 313: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 314: 7.45 Paeonia lactiflora (Peony)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 315: 7.45.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 315: 7.45.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 315: 7.45.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 315: 7.45.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 316: 7.45.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 316: 7.45.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 317: 7.45.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 317: 7.45.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 317: 7.45.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 317: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 318: 7.46 Panax ginseng (Ginseng)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 319: 7.46.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 320: 7.46.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 320: 7.46.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 320: 7.46.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 321: 7.46.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 322: 7.46.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 322: 7.46.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 322: 7.46.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 322: 7.46.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 323: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 324: 7.47 Passifloraceae incarnata (Passionflower)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 325: 7.47.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 325: 7.47.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 325: 7.47.3 Antidiabetic\/Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 326: 7.47.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 326: 7.47.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 327: 7.47.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 327: 7.47.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 327: 7.47.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 327: 7.47.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 327: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 329: 7.48 Piper methysticum (Kava)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 329: 7.48.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 330: 7.48.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 330: 7.48.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 330: 7.48.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 331: 7.48.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 331: 7.48.6 Safety\/Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 333: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 334: 7.49 Piper nigrum (Black Pepper)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 334: 7.49.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 334: 7.49.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 335: 7.49.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 335: 7.49.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 336: 7.49.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 336: 7.49.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 337: 7.49.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 337: 7.49.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 337: 7.49.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 337: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 338: 7.50 Polygala tenuifolia<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 339: 7.50.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 340: 7.50.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 340: 7.50.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 340: 7.50.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 342: 7.50.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 343: 7.50.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 343: 7.50.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 343: 7.50.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 343: 7.50.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 343: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 345: 7.51 Poria cocos<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 346: 7.51.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 346: 7.51.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 346: 7.51.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 346: 7.51.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: 7.51.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: 7.51.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: 7.51.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: 7.51.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: 7.51.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 347: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 348: 7.52 Psoralea corylifolia<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 349: 7.52.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 349: 7.52.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 350: 7.52.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 351: 7.52.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 352: 7.52.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 352: 7.52.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 352: 7.52.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 353: 7.52.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 353: 7.52.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 353: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 355: 7.53 Rhodiola rosea<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 355: 7.53.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 356: 7.53.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 356: 7.53.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 357: 7.53.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 358: 7.53.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 359: 7.53.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 359: 7.53.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 359: 7.53.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 359: 7.53.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 359: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 360: 7.54 Rosmarinus officinalis (Rosemary)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 361: 7.54.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 361: 7.54.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 362: 7.54.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 363: 7.54.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 363: 7.54.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 364: 7.54.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 364: 7.54.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 364: 7.54.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 364: 7.54.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 364: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 366: 7.55 Salvia divinorum<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 367: 7.55.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 367: 7.55.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 367: 7.55.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 367: 7.55.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 368: 7.55.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 369: 7.55.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 370: 7.55.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 370: 7.55.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 370: 7.55.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 370: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 371: 7.56 Sceletium tortuosum<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 372: 7.56.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 373: 7.56.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 373: 7.56.3 Antidiabetic\/Antimetabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 373: 7.56.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 374: 7.56.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 375: 7.56.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 375: 7.56.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 375: 7.56.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 375: 7.56.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 375: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 376: 7.57 Schisandra chinensis<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 377: 7.57.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 377: 7.57.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 378: 7.57.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 378: 7.57.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: 7.57.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: 7.57.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: 7.57.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: 7.57.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: 7.57.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 379: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 381: 7.58 Scutellaria lateriflora (Skullcap)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 381: 7.58.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 381: 7.58.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 381: 7.58.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 382: 7.58.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 383: 7.58.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 383: 7.58.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 384: 7.58.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 384: 7.58.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 384: 7.58.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 384: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 385: 7.59 Silybum marianum (Milk Thistle)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 386: 7.59.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 387: 7.59.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 387: 7.59.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 387: 7.59.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 389: 7.59.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 389: 7.59.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 389: 7.59.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 390: 7.59.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 390: 7.59.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 390: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 391: 7.60 Theobroma cacao (Chocolate)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 392: 7.60.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 392: 7.60.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 393: 7.60.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 393: 7.60.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 393: 7.60.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 394: 7.60.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 395: 7.60.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 395: 7.60.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 395: 7.60.9 Drug Interaction<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 396: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 397: 7.61 Tilia (Linden)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 397: 7.61.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 398: 7.61.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 398: 7.61.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 398: 7.61.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 399: 7.61.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 399: 7.61.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 399: 7.61.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 399: 7.61.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 399: 7.61.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 400: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 401: 7.62 Trigonella foenum-graecum (Fenugreek)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 402: 7.62.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 402: 7.62.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 403: 7.62.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 404: 7.62.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 405: 7.62.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 405: 7.62.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 405: 7.62.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 406: 7.62.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 406: 7.62.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 406: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 408: 7.63 Valeriana officinalis (Valerian)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 409: 7.63.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 409: 7.63.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 410: 7.63.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 410: 7.63.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 411: 7.63.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 411: 7.63.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 412: 7.63.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 412: 7.63.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 412: 7.63.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 412: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 413: 7.64 Verbena officinalis (Vervain)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 414: 7.64.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 415: 7.64.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 415: 7.64.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 416: 7.64.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 417: 7.64.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 417: 7.64.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 417: 7.64.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 417: 7.64.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 417: 7.64.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 418: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 419: 7.65 Vitex agnus-castus (Chaste Tree)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 419: 7.65.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 420: 7.65.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 420: 7.65.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 420: 7.65.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 420: 7.65.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 422: 7.65.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 422: 7.65.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 422: 7.65.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 422: 7.65.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 423: References<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 424: 7.66 Withania somnifera (Ashwagandha)<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 424: 7.66.1 Antioxidant<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 425: 7.66.2 Anti-Inflammatory<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 425: 7.66.3 Antidiabetic\/Anti-Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 426: 7.66.4 Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 427: 7.66.5 Human Antidepressant Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 427: 7.66.6 Dosage<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 427: 7.66.7 Toxicity<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 427: 7.66.8 Safety in Pregnancy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 427: 7.66.9 Drug Interactions<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 428: References<\/li>\n<li>Page 430: Chapter 8 The Antidepressant Effects of Yueue and the Herbs of Traditional Chinese Medicine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 430: 8.1 Fundamental Considerations<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 431: 8.2 Yueju<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 433: 8.3 Xiao Yao San<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 434: 8.4 Chai Hu Shu Gan<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 435: 8.5 Gan Mai Da Zao<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 436: 8.6 Gui Pi<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 436: 8.7 Shi Wei Wen Dan Tang<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 437: 8.8 Ban Xia Hou Pu<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 437: 8.9 Chai Hu Jia Long Gu Mu Li<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 438: 8.10 Tiao Qi<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 438: 8.11 Yi Pi<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 438: 8.12 Tang Shen Kang<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 438: 8.13 Kai Xin San<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 439: 8.14 Shu Gan Jie Yu<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 440: 8.15 Si Ni San<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 440: 8.16 Wu Ling<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 441: 8.17 Other TCM Herbs Used in the Treatment of MDD<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 443: 8.18 A Medical \u201cTheory of Everything\u201d<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 444: References<\/li>\n<li>Page 448: Chapter 9 Flavonoids with Preclinical Antidepressant-Like Effects<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 448: 9.1 Amentoflavone<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 449: 9.2 Apigenin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 449: 9.3 Astilbin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 450: 9.4 Baicalein and Baicalin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 450: 9.5 Chrysin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 450: 9.6 7,8,Dihydroxyflavone<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 452: 9.7 Fisetin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 452: 9.8 Heptomethoxyflavone<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 453: 9.9 Hesperidin and Hesperitin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 454: 9.10 Hyperoside<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 454: 9.11 Icariin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 454: 9.12 Isosakurentin-5-O-rutinoside<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 455: 9.13 Kaempferol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 455: 9.14 Liquiritin and Isoliquirtin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 455: 9.15 Luteolin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 456: 9.16 Miquelianin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 456: 9.17 Myricetin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 456: 9.18 Naringenin and Naringin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 457: 9.19 Nobiletin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 458: 9.20 Orientin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 458: 9.21 Quercetin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 460: 9.22 Vitexin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 460: 9.23 Wogonin and Wogonoside<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 460: 9.24 Synthetic Flavonoids<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 461: 9.25 Mechanisms of Flavonoid Antidepressant Action<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 466: References<\/li>\n<li>Page 473: Chapter 10 Preclinical Antidepressant-Like Effects of Terpenes, Polyphenolics, and Other Non-Flavonoid Phytochemicals<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 475: 10.1 Amyrins<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 475: 10.2 Bacopasides<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 476: 10.3 Berberine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 478: 10.4 3-n-Butylphthalide<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 478: 10.5 Caffeic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 479: 10.6 \u03b2-Carotene<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 479: 10.7 Carvacrol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 480: 10.8 \u03b2-Caryophyllene<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 480: 10.9 Chlorogenic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 480: 10.10 Crocin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 481: 10.11 Curcumin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 481: 10.12 3,6\u2032\u2010Disinapoyl Sucrose<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 482: 10.13 Ellagic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 482: 10.14 Eugenol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 483: 10.15 Ferulic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 484: 10.16 Gallic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 485: 10.17 Gastrodin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 486: 10.18 Genipin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 487: 10.19 Ginsenoside Rg1<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 488: 10.20 Glycyrrhizin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 488: 10.21 4-Hydroxyisoleucine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 489: 10.22 Hyperfoliatin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 489: 10.23 Linalool<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 489: 10.24 Macranthol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 490: 10.25 Methyl Jasmonate<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 491: 10.26 Mitragynine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 491: 10.27 Oleanolic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 492: 10.28 Orcinol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 492: 10.29 Paeoniflorin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 494: 10.30 Paeonol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 494: 10.31 Palmatine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 495: 10.32 Plumbagin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 496: 10.33 Podoandin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 496: 10.34 Punarnavine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 496: 10.35 Resveratrol<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 498: 10.36 Riparin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 498: 10.37 Rosmarinic Acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 499: 10.38 Safranal<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 499: 10.39 Salidroside<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 500: 10.40 Sarsasapogenin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 501: 10.41 Scopoletin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 502: 10.42 Sulphoraphane<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 502: 10.43 Tetrandrine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 503: 10.44 L\u2010theanine<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 503: 10.45 Uliginosin B<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 503: 10.46 Ursolic acid<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 504: 10.47 Vanillin<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 504: References<\/li>\n<li>Page 517: Chapter 11 Choosing Herbal Treatments<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 518: 11.1 Efficacy of Herbal Treatments of MDD<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 521: 11.2 Herbs for Which There Is Less than Compelling Evidence of Efficacy<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 523: 11.3 Combinations of Herbs<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 525: 11.4 Addressing Comorbidities<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 525: 11.4.1 Anxiety and Insomnia<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 528: 11.4.2 Obsessive-Compulsive Disorder<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 528: 11.4.3 Premenstrual and Perimenopausal Symptoms<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 530: 11.4.4 Dementia<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 530: 11.4.5 Diabetes and Metabolic Syndrome<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 531: 11.4.6 Fatigue, Lack of Resiliency, and General Malaise<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 534: 11.5 Augmentation of Standard Antidepressant Treatment with Herbs<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 535: 11.6 Safety<\/li>\n<li>&nbsp;&nbsp;&nbsp;&nbsp;Page 537: References<\/li>\n<li>Page 546: Index<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"PDF_Download\"><\/span>PDF Download<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align:center;\"><a href=\"https:\/\/1kitap1.com\/en\/wp-content\/uploads\/2026\/07\/herbal-treatment-of-major-depression-mendelson-scott-d.pdf\" download rel=\"nofollow\" style=\"display:inline-block;background:#2271b1;color:#ffffff;padding:14px 36px;border-radius:6px;text-decoration:none;font-weight:bold;font-size:1.05em;\">&#11015;&#65039; Herbal Treatment of Major Depression Download<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The German Commission E has approved Humulus lupulus for the treatment of restlessness, anxiety, mood disturbances, and sleep disturbances.12 In an open-labeled study, nightly consumption of non- alcoholic beer, a good source of Humulus lupulus, significantly improved sleep and eased anxiety.13 There is only one published report on the effects of Humulus lupulus on MDD [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":262554,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[54320],"class_list":["post-262556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-english","tag-mendelson-scott-d"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/posts\/262556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/comments?post=262556"}],"version-history":[{"count":0,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/posts\/262556\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/media\/262554"}],"wp:attachment":[{"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/media?parent=262556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/categories?post=262556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1kitap1.com\/en\/wp-json\/wp\/v2\/tags?post=262556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}